Inventor

BENJAMIN ELFRIDA

US57 patents

⚠️ This page may combine multiple inventors who share the name “BENJAMIN ELFRIDA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BENJAMIN ELFRIDA

AMICUS THERAPEUTICS INC

Methods of treating fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene

Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene

Method to predict response to pharmacological chaperone treatment of diseases

Method to predict response to pharmacological chaperone treatment of diseases

Method to predict response to pharmacological chaperone treatment of diseases

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry patients having renal impairment

Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene

Methods of treating Fabry patients having renal impairment

Methods of treating Fabry disease in patients having a mutation in the GLA gene

Methods of treating fabry patients having renal impairment

BENJAMIN ELFRIDA

Method to predict response to pharmacological chaperone treatment of diseases

AMICUS THERAPEUTICS

Method to predict response to pharmacological chaperone treatment of diseases